PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsBenzodiazepine
Benzodiazepine
Benzodiazepine is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Searched
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
— N03: Antiepileptics
— N03A: Antiepileptics
— N03AE: Benzodiazepine derivative antiepileptics
— N05: Psycholeptics
— N05B: Anxiolytics
— N05BA: Benzodiazepine derivative anxiolytics
— N05C: Hypnotics and sedatives
— N05CD: Benzodiazepine derivative hypnotics and sedatives
— N05CF: Benzodiazepine related hypnotics and sedatives
HCPCS
Code
Description
G0033
Two or more benzodiazepine prescriptions ordered for patients who had a diagnosis of seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, or severe generalized anxiety disorder on or between january 1 of the year prior to the measurement period and the ipsd for benzodiazepines
Clinical
Clinical Trials
2100 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———24543815274
SchizophreniaD012559EFO_0000692F201826466839192
Anxiety disordersD001008EFO_0006788F41.110106252878
Bipolar disorderD001714EFO_0000289F30.94520351275
NeoplasmsD009369—C804312133872
Psychotic disordersD011618—F20.815514351472
DepressionD003863—F33.9111515191668
VomitingD014839—R11.13182671060
AnxietyD001007EFO_0005230F41.1863162757
Depressive disorderD003866EFO_1002014F32.A101011171054
Show 299 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chronic painD059350——1—1—68
Hematologic neoplasmsD019337——124—17
Covid-19D000086382—U07.13—1—37
Neoplasm metastasisD009362EFO_0009708—422—17
Acute painD059787—R52—22—47
Personality disordersD010554—F60.6—12—47
HypotensionD007022EFO_0005251I95—12—47
Renal insufficiencyD051437—N193—3——6
Low back painD017116—M54.5122—26
Back painD001416—M54112—36
Show 89 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Drug interactionsD004347——241——428
Cocaine-related disordersD019970—F1433——27
Colorectal neoplasmsD015179——32——16
TuberculosisD014376EFO_0000774A15-A1951———6
Parkinson diseaseD010300EFO_0002508G2023——15
Stomach neoplasmsD013274EFO_0003897C16—2——35
Drug overdoseD062787——11——35
CarcinomaD002277—C80.021——14
LeukemiaD007938—C9543———4
Myeloid leukemia acuteD015470—C92.043———4
Show 75 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ArthritisD001168EFO_0005856M05-M146———39
PsoriasisD011565EFO_0000676L408————8
Rheumatoid arthritisD001172EFO_0000685M06.96———28
Heart failureD006333EFO_0003144I502———46
InfectionsD007239EFO_0000544—4———26
Atopic dermatitisD003876EFO_0000274L205————5
Non-hodgkin lymphomaD008228—C85.93———14
MelanomaD008545——4————4
Acquired immunodeficiency syndromeD000163EFO_0000765B204————4
Food-drug interactionsD018565——4————4
Show 123 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypoxiaD000860—R09.02————55
Cardiac arrhythmiasD001145EFO_0004269I49.9————44
DeprescriptionsD000069340——————44
Narcotic-related disordersD000079524——————33
TachycardiaD013610—R00.0————33
Atrial fibrillationD001281EFO_0000275I48.0————33
Postpartum depressionD019052EFO_0007453F53.0————33
MenorrhagiaD008595EFO_0003945N92.0————22
Hemophilia aD006467EFO_0007267D66————22
PneumoniaD011014EFO_0003106J18————22
Show 186 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameBenzodiazepine
INN—
Description
Benzodiazepines (BZD, BDZ, BZs), colloquially called "benzos", are a class of depressant drugs whose core chemical structure is the fusion of a benzene ring and a diazepine ring. They are prescribed to treat conditions such as anxiety disorders, insomnia, and seizures. The first benzodiazepine, chlordiazepoxide (Librium), was discovered accidentally by Leo Sternbach in 1955 and was made available in 1960 by Hoffmann–La Roche, who soon followed with diazepam (Valium) in 1963. By 1977, benzodiazepines were the most prescribed medications globally; the introduction of selective serotonin reuptake inhibitors (SSRIs), among other factors, decreased rates of prescription, but they remain frequently used worldwide.
Classification
Small molecule
Drug classtricyclic compounds
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
C1=Cc2ccccc2NN=C1
Identifiers
PDB—
CAS-ID12794-10-4
RxCUI—
ChEMBL IDCHEMBL4297264
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 9,999 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
3,608 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use